Needle-Free blood vessel connection for dialysis patients tested

NCT ID NCT02682420

Terminated Disease control Sponsor: C. R. Bard Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device called everlinQ endoAVF that creates a connection between an artery and a vein using a thin tube (catheter) instead of open surgery. The goal was to make it easier for people with chronic kidney disease to get dialysis. The trial enrolled 100 adults who needed or were about to start dialysis. However, the study was stopped early, so we don't have full results on how well it worked.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: everlinQ endoAVF System (a device that creates a connection between an artery and vein using a catheter, avoiding open surgery)
What this could lead to: If successful, this device could provide a less invasive way to create dialysis access, potentially reducing surgery risks and recovery time.
What could go wrong: The trial was terminated early, so results are limited. The device may not work for all patients, and complications like clotting or narrowing of the fistula can still occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE

Contacts and locations

Locations

Dominikus Hospital

Düsseldorf, Germany
Manchester University NHS Foundation Trust

Manchester, M13 9WL, United Kingdom
Oxford University Hospitals - NHS Foundation Trust

Headington, Oxford, OX3 9DU, United Kingdom
Providence Health Care Society

Vancouver, British Columbia, V6Z 2K5, Canada
St. Franziskus-Hospital Münster

Münster, Germany
St. George's University

London, United Kingdom
University Hospital Carl Gustav Carus

Dresden, Germany
University Hospitals Birmingham

Birmingham, United Kingdom
University of Frankfurt

Frankfurt, Germany
University of Leipzig

Leipzig, Germany
University of Mannheim

Mannheim, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.